HuGE Literature Finder
Records
1
-
30
| A lung adenocarcinoma patient with co-mutations of MET and EGFR exon20 insertion responded to crizotinib. BMC medical genomics 2022 Jun 15 (1): 141. Chen Yan, Jiang Bo, He Yuange, Zhang Chu, Zhou Wenjie, Fang Cheng, Gu Dejian, Zhang Minxia, Ji Mei, Shi Juntao, Yang X |
| Distinct mechanisms of innate and adaptive immune regulation underlie poor oncologic outcomes associated with KRAS-TP53 co-alteration in pancreatic cancer. Oncogene 2022 Jun . Datta Jashodeep, Bianchi Anna, De Castro Silva Iago, Deshpande Nilesh U, Cao Long Long, Mehra Siddharth, Singh Samara, Rafie Christine, Sun Xiaodian, Chen Xi, Dai Xizi, Colaprico Antonio, Sharma Prateek, Dosch Austin R, Pillai Asha, Hosein Peter J, Nagathihalli Nagaraj S, Komanduri Krishna V, Wilson Julie M, Ban Yuguang, Merchant Nipun |
| Mutation of KRAS in colorectal adenocarcinoma in Greenland. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2022 Jun . Mousavi Nabi, Truelsen Sarah Line Bring, Bernth-Andersen Simon, Koch Anders, Heegaard Steff |
| Genomic Landscape of Actionable Mutations in Primary and Metastatic Tissues of Colon Adenocarcinoma. Cureus 2022 Apr 14 (4): e24175. Yekedüz Emre, Akbulut Hakan, Utkan Güngör, Ürün Yüks |
| The genetic landscape of pancreatic head ductal adenocarcinoma in China and prognosis stratification. BMC cancer 2022 Feb 22 (1): 186. Yang Yefan, Ding Ying, Gong Yuxi, Zhao Sha, Li Mingna, Li Xiao, Song Guoxin, Zhai Boya, Liu Jin, Shao Yang, Zhu Liuqing, Pang Jiaohui, Ma Yutong, Ou Qiuxiang, Wu Xue, Zhang Zhiho |
| The Genomics of Colorectal Cancer in Populations with African and European Ancestry. Cancer discovery 2022 Feb . Myer Parvathi A, Lee Jessica K, Madison Russell W, Pradhan Kith, Newberg Justin Y, Isasi Carmen R, Klempner Samuel J, Frampton Garrett M, Ross Jeffrey S, Venstrom Jeffrey M, Schrock Alexa B, Das Sudipto, Augenlicht Leonard, Verma Amit, Greally John M, Raj Srilakshmi M, Goel Sanjay, Ali Siraj |
| Correlation between Programmed Death Ligand-1(PD-L1) Expression and Driver Gene Mutations in Non-Small Cell Lung Carcinoma- Adenocarcinoma Phenotype. Asian Pacific journal of cancer prevention : APJCP 2022 Jan 23 (1): 131-142. Pandey Rahul Kumar, Shukla Saumya, Husain Nuzhat, Islam Mohammad Hayatul, Hadi Rahat, Kant Tripathi Surya, Singhal Ashi |
| Genetic alteration and PD-L1 expression profiles of Chinese patients with lung squamous cell carcinoma. Pathology, research and practice 2022 Jan 231 153761. Chen Ying, Kong Wencui, Yu Zongyang, Zhao Zhongqu |
| Loss of STING expression is prognostic in non-small cell lung cancer. Journal of surgical oncology 2022 Jan . Lohinai Zoltan, Dora David, Caldwell Charles, Rivard Christopher J, Suda Kenichi, Yu Hui, Rivalland Gareth, Ellison Kim, Rozeboom Leslie, Dziadziuszko Rafal, Mitchell Paul, John Thomas, Millan Inigo S, Ren Shengxiang, Hirsch Fred |
| Detection and Significance of Cell-Free DNA Mutation in Pleural Effusion in Patients with Advanced NSCLC. Emergency medicine international 2022 2022 3112281. Qiao Man, Li Dongsheng, He Yuan, Zhang Cen, Chi Hang, Li Xiaoqiu, Cui QingMing, Li ShaoYing, Jiao Ying, Wei Yu |
| KRAS gene mutation quantification in the resection or venous margins of pancreatic ductal adenocarcinoma is not predictive of disease recurrence. Scientific reports 2022 02 12 (1): 2976. Amintas Samuel, Fernandez Benjamin, Chauvet Alexandre, Chiche Laurence, Laurent Christophe, Belleannée Geneviève, Marty Marion, Buscail Etienne, Dabernat Sandri |
| Prevalence of targeted therapy-related genetic variations in NSCLC and their relationship with clinicopathological characteristics. PloS one 2022 17 (1): e0262822. Li Fanghua, Ye Peng, Cai Peiling, Dong Dandan, Zhang Yihao, Yang Yue, Sun Xingwa |
| Prognostic Impact of Tumor Budding on Moroccan Colon Cancer Patients. International journal of surgical oncology 2022 2022 9334570. El Agy Fatima, El Bardai Sanae, Bouguenouch Laila, Lahmidani Nada, El Abkari Mohammed, Benjelloun El Bachir, Ousadden Abdelmalek, Mazaz Khalid, ImaneToughrai , Ibrahimi Sidi Adil, Benbrahim Zineb, Chbani Lai |
| Diminished efficacy of PD-(L)1 inhibition in STK11- and KEAP1-mutant lung adenocarcinoma is impacted by KRAS mutation status. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2021 Nov . Ricciuti Biagio, Arbour Kathryn C, Lin Jessica J, Vajdi Amir, Vokes Natalie, Hong Lingzhi, Zhang Jianjun, Tolstorukov Michael Y, Li Yvonne Y, Spurr Liam F, Cherniack Andrew D, Recondo Gonzalo, Lamberti Giuseppe, Wang Xinan, Venkatraman Deepti, Alessi Joao V, Vaz Victor R, Rizvi Hira, Egger Jacklynn, Plodkowski Andrew J, Khosrowjerdi Sara, Digumarthy Subba, Park Hyesun, Vaz Nuno, Nishino Mizuki, Sholl Lynette M, Barbie David, Altan Mehmet, Heymach John V, Skoulidis Ferdinandos, Gainor Justin F, Hellmann Matthew D, Awad Mark |
| Microsatellite Instability Is Rare in the Admixed Brazilian Population of Non-Small Cell Lung Cancer: A Cohort of 526 Cases. Pathobiology : journal of immunopathology, molecular and cellular biology 2021 Nov 1-6. De Marchi Pedro, Berardinelli Gustavo Noriz, Cavagna Rodrigo de Oliveira, Pinto Icaro Alves, da Silva Flavio Augusto Ferreira, Duval da Silva Vinicius, Santana Iara Viana Vidigal, da Silva Eduardo Caetano Albino, Ferro Leal Leticia, Reis Rui Manu |
| Mutational profiles of primary pulmonary adenocarcinoma and paired brain metastases disclose the importance of KRAS mutations. European journal of cancer (Oxford, England : 1990) 2021 Nov 159 227-236. Vassella Erik, Kashani Elham, Zens Philipp, Kündig Alexandra, Fung Christian, Scherz Amina, Herrmann Evelyn, Ermis Ekin, Schmid Ralph A, Berezowska Sabi |
| p.G12C KRAS mutation prevalence in non-small cell lung cancer: Contribution from interregional variability and population substructures among Hispanics. Translational oncology 2021 Nov 15 (1): 101276. Ruiz-Patiño Alejandro, Rodríguez July, Cardona Andrés F, Ávila Jenny, Archila Pilar, Carranza Hernán, Vargas Carlos, Otero Jorge, Arrieta Oscar, Zatarain-Barrón Lucia, Sotelo Carolina, Ordoñez Camila, García-Robledo Juan Esteban, Rojas Leonardo, Bermúdez Maritza, Gámez Tatiana, Mayorga Diana, Corrales Luis, Martín Claudio, Recondo Gonzalo, Mas Luis, Samtani Suraj, Ricaurte Luisa, Malapelle Umberto, Russo Alessandro, Barrón Feliciano, Santoyo Nicolas, Rolfo Christian, Rosell Rafael, , |
| Prognostic role of cell-free DNA biomarkers in pancreatic adenocarcinoma: A systematic review and meta-analysis. Critical reviews in oncology/hematology 2021 Nov 103548. Bunduc Stefania, Gede Noémi, Váncsa Szilárd, Lillik Veronika, Kiss Szabolcs, Dembrovszky Fanni, Eross Bálint, Szakács Zsolt, Gheorghe Cristian, Mikó Alexandra, Hegyi Pét |
| Optimal value of CA19-9 determined by KRAS-mutated circulating tumor DNA contributes to the prediction of prognosis in pancreatic cancer patients. Scientific reports 2021 Oct 11 (1): 20797. Watanabe Fumiaki, Suzuki Koichi, Tamaki Sawako, Abe Iku, Endo Yuhei, Takayama Yuji, Ishikawa Hideki, Kakizawa Nao, Saito Masaaki, Futsuhara Kazushige, Noda Hiroshi, Konishi Fumio, Rikiyama Toshi |
| Plasma KRAS mutations predict the early recurrence after surgical resection of pancreatic cancer. Cancer biology & therapy 2021 Oct 1-7. Ako Soichiro, Kato Hironari, Nouso Kazuhiro, Kinugasa Hideaki, Terasawa Hiroyuki, Matushita Hiroshi, Takada Saimon, Saragai Yosuke, Mizukawa Sho, Muro Shinichiro, Uchida Daisuke, Tomoda Takeshi, Matsumoto Kazuyuki, Horiguchi Shigeru, Nobuoka Daisuke, Yoshida Ryuichi, Umeda Yuzo, Yagi Takahito, Okada Hiroyu |
| Associations between tumor mutations in cfDNA and survival in non-small cell lung cancer. Cancer treatment and research communications 2021 Sep 29 100471. Ottestad Anine Larsen, Dai Hong Yan, Halvorsen Tarje Onsøien, Emdal Elisabeth Fritzke, Wahl Sissel Gyrid Freim, Grønberg Bjørn Henni |
| Evaluation of KRAS Concomitant Mutations in Advanced Lung Adenocarcinoma Patients. Medicina (Kaunas, Lithuania) 2021 Sep 57 (10): . Aran Veronica, Zalis Mariano, Montella Tatiane, de Sousa Carlos Augusto Moreira, Ferrari Bruno L, Gil Ferreira Carl |
| Programmed death-ligand 1 expression and its associations with clinicopathological features, prognosis, and driver oncogene alterations in surgically resected lung adenocarcinoma. Lung cancer (Amsterdam, Netherlands) 2021 Sep 161 163-170. Takamochi Kazuya, Hara Kieko, Hayashi Takuo, Kohsaka Shinji, Takahashi Fumiyuki, Suehara Yoshiyuki, Suzuki Ken |
| PD-L1 expression, EGFR and KRAS mutations and survival among stage III unresected non-small cell lung cancer patients: a Danish cohort study. Scientific reports 2021 Aug 11 (1): 16892. Cronin-Fenton Deirdre, Dalvi Tapashi, Movva Naimisha, Pedersen Lars, Hansen Hanh, Fryzek Jon, Hedgeman Elizabeth, Mellemgaard Anders, Rasmussen Torben R, Shire Norah, Hamilton-Dutoit Stephen, Nørgaard Met |
| Driver and novel genes correlated with metastasis of non-small cell lung cancer: A comprehensive analysis. Pathology, research and practice 2021 Jul 224 153551. Wu Yongfeng, Ni Heng, Yang Dexin, Niu Yuequn, Chen Kelie, Xu Jinming, Wang Fang, Tang Song, Shi Yu, Zhang Honghe, Hu Jian, Xia Dajing, Wu Yih |
| Frequency of actionable molecular drivers in lung cancer patients with precocious brain metastases. Clinical neurology and neurosurgery 2021 Jul 208 106841. Hanke Benjamin, Jünger Stephanie T, Kirches Elmar, Waldt Natalie, Schreiber Jens, Lücke Eva, Franke Sabine, Sandalcioglu I Erol, Warnke Jan-Peter, Meisel Hans-Jörg, Prell Julian, Scheller Christian, Braunsdorf Werner E K, Preusser Matthias, Schildhaus Hans-Ulrich, Mawrin Christi |
| Retrospective analysis of eleven gene mutations, PD-L1 expression and clinicopathological characteristics in non-small cell lung cancer patients. Asian journal of surgery 2021 Jul . Liu Yanqing, Wu Aihua, Li Xinjian, Wang Shanshan, Fang Shuyu, Mo Yij |
| The Absence of Mutations in the Exon 2 KRAS Gene in Several Ethnic Groups in North Sumatra May Not the Main Factor for Lung Cancer. Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH 2021 Jun 29 (2): 108-112. Soeroso Noni Novisari, Ananda Fannie Rizki, Pradana Andika, Tarigan Setia Putra, Syahruddin Elisna, Noor Dimas Ramadhi |
| Evaluation on the Distribution of EGFR, KRAS and BRAF Genes and the Expression of PD-L1 in Different Types of Lung Cancer. International journal of general medicine 2021 14 5615-5620. Zhao Rui, Gao Shan, He Haiqi, Zhang Jia, Zhang Guangjian, Wen Xiaope |
| Prognostic Value of KRAS Gene Mutation on Survival of Patients with Peritoneal Metastases of Colorectal Adenocarcinoma. International journal of surgical oncology 2021 2021 3946875. Díez-Alonso Manuel, Mendoza-Moreno Fernando, Gómez-Sanz Remedios, Matías-García Belén, Ovejero-Merino Enrique, Molina Raquel, Soto-Schütte Sonia, San Juan Alberto, Gutierrez-Calvo Alber |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 28, 2022
- Content source: